CKD中循环FGF23、HRG-HMGB1与心脏病的网络相互作用
该研究对欧洲血统人群五种矿物质代谢标志物的GWAS进行多性状分析(MTAG),将FGF23的有效样本量提升至n=50,325,并鉴定出62个全基因组显著位点。功能基因组学方法发现富组氨酸糖蛋白(HRG)和高迁移率族蛋白B1(HMGB1)是循环FGF23下游通路的中心调控因子,且在已故血液透析患者肥厚心肌组织中高度富集。研究提示MTAG可增强FGF23遗传位点发现,HRG和HMGB1是CKD中FGF23与心血管疾病的关键调控因子。
要点
- MTAG将FGF23有效样本量提升至n=50,325,鉴定出62个全基因组显著位点。
- HRG和HMGB1被识别为循环FGF23下游通路的中心调控因子。
- HRG和HMGB1在已故血液透析患者肥厚心肌组织中高度富集。
核心结论
- MTAG分析矿物质代谢标志物可增加FGF23全基因组显著位点数量,功能基因组学揭示HRG和HMGB1是CKD中FGF23与心血管疾病的关键调控因子。
研究设计与样本
- 对欧洲血统人群五种遗传相关矿物质代谢标志物的GWAS进行多性状分析(MTAG)。
- 整合UK Biobank的磷酸盐、25-羟基维生素D和钙GWAS(n=366,484)与CHARGE联盟的甲状旁腺激素(n=29,155)和FGF23(n=13,716)GWAS。
- 采用监督和无监督深度机器学习识别遗传特征与FGF23的新关联。
主要发现
- MTAG将FGF23的有效样本量提升至n=50,325。
- 连锁不平衡 clumping 后,MTAG为所有性状识别出独立的全基因组显著单核苷酸多态性,包括FGF23的62个位点。
- 许多FGF23位点未在单性状分析中报道过。
- 功能基因组学方法识别HRG和HMGB1为循环FGF23相关下游经典通路的中心调控因子。
- HRG和HMGB1在已故血液透析患者肥厚心肌组织中高度富集。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: Multitrait analysis of genome-wide association study boosts the statistical power to identify novel genetic traits for fibroblast growth factor 23. A functional genomics approach aided network discovery to identify histidine-rich glycoprotein (HRG) and high-mobility group protein box 1 (HMGB1) as key regulators of cardiac disease in CKD. Integration of clinical and genetic data enhances the discovery power and is crucial for understanding the genetic underpinnings of mineral bone disorder related to CKD. BACKGROUND: Genome-wide association studies (GWAS) have identified numerous genetic loci associated with mineral metabolism markers but have exclusively focused on single-trait analysis. In this study, we performed a multitrait analysis of GWAS (MTAG) of mineral metabolism, exploring overlapping genetic architecture between traits to identify novel genetic associations for fibroblast growth factor 23 (FGF23). METHODS: We applied MTAG to variants common to GWAS of five genetically correlated mineral metabolism markers in participants of European ancestry. We integrated UK Biobank GWAS for blood levels for phosphate, 25-hydroxyvitamin D, and calcium (n=366,484) and Cohorts for Heart and Aging Research in Genetic Epidemiology GWAS for parathyroid hormone (n=29,155) and FGF23 (n=13,716). We then used supervised and unsupervised deep machine learning to identify novel associations between genetic traits and FGF23. RESULTS: MTAG increased the effective sample size for mineral metabolism markers to n=50,325 for FGF23. After clumping, MTAG identified independent genome-wide significant single-nucleotide polymorphisms for all traits, including 62 loci for FGF23. Many of these loci have not been previously reported in single-trait analyses. Through a functional genomics approach, we identified histidine-rich glycoprotein (HRG) and high-mobility group box 1 (HMGB1) as master regulators of downstream canonical pathways associated with circulating FGF23, and both genes were highly enriched in hypertrophied cardiac tissue of deceased hemodialysis patients. In addition, we found that DNMT3A was associated with uremic toxin, 8-hydroxy-2-deoxyguanosine, a biomarker of DNA damage. In silico gene perturbation analysis revealed that DNMT3A is protective in patients with heart failure caused by hypertrophied or dilated cardiomyopathy. CONCLUSIONS: Our findings highlight the importance of MTAG analysis of mineral metabolism markers to boost the number of genome-wide significant loci for FGF23 to identify novel genetic traits. Functional genomics revealed novel networks that inform unique cellular functions and identified HRG and HMGB1 as key master regulators of FGF23 and cardiovascular disease in CKD.
引用
- Perwad F, Akwo EA, Singhal A, et al. Network Interactions of Circulating FGF23, HRG-HMGB1, and Cardiac Disease in CKD. J Am Soc Nephrol. 2025. PMID: 40238264. doi:10.1681/ASN.0000000710
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。